Marek Lommatzsch

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Allergy

Respiratory research

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Marek Lommatzsch, Marieke Dost, Neeraja Jaishankar, Martin Weise, Paul Stoll, Johann Christian Virchow, Kai Bratke
Dupilumab treatment increases transitional B cells in severe asthma. Allergy (2023)
Marek Lommatzsch, Marieke Dost, Neeraja Jaishankar, Martin Weise, Paul Stoll, Johann Christian Virchow, Kai Bratke
Dupilumab treatment increases transitional B cells in severe asthma. Allergy (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Marek Lommatzsch, Timotheus Speer, Christian Herr, Rudolf A Jörres, Henrik Watz, Achim Müller, Tobias Welte, Claus F Vogelmeier, Robert Bals, null null
IgE is associated with exacerbations and lung function decline in COPD. Respiratory research 23 (1) (2022)
Marek Lommatzsch, Hendrik Suhling, Stephanie Korn, Karl-Christian Bergmann, Jens Schreiber, Thomas Bahmer, Klaus F Rabe, Roland Buhl, Johann Christian Virchow, Katrin Milger
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations. Allergy 77 (9) (2022)
Marek Lommatzsch, Paul Stoll, Jörg Winkler, Daniel Zeise-Wehry, Michael Tronnier, Marc-André Weber, Johann Christian Virchow
Eosinophilic pleural effusion and stroke with cutaneous vasculitis: Two cases of dupilumab-induced hypereosinophilia. Allergy 76 (9) (2021)
Marek Lommatzsch, Maria Klein, Paul Stoll, Johann Christian Virchow
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma. Allergy 76 (10) (2021)
Marek Lommatzsch, Paul Stoll, Johann Christian Virchow
COVID-19 in a patient with severe asthma treated with Omalizumab. Allergy 75 (10) (2020)
Marek Lommatzsch, Hannes Marchewski, Georg Schwefel, Paul Stoll, Johann Christian Virchow, Kai Bratke
Benralizumab strongly reduces blood basophils in severe eosinophilic asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 50 (11) (2020)

Marek Lommatzsch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marek Lommatzsch